<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lin YC</submitter><funding>NIEHS NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>1461-8</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4076807</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>35(7)</volume><pubmed_abstract>Aflatoxin B1 (AFB1) is a known carcinogen associated with early-onset hepatocellular carcinoma (HCC) and is thought to contribute to over half a million new HCCs per year. Although some of the fundamental risk factors are established, the molecular basis of AFB1-induced mutagenesis in primate cells has not been rigorously investigated. To gain insights into genome instability that is produced as a result of replicating DNAs containing AFB1 adducts, site-specific mutagenesis assays were used to establish the mutagenic potential of the persistent ring-opened AFB1 adduct, AFB1-formamidopyrimidine (AFB1-FAPY). This lesion was highly mutagenic, yielding replication error frequencies of 97%, with the predominant base substitution being a G to T transversion. This transversion is consistent with previous mutational data derived from aflatoxin-associated HCCs. In vitro translesion synthesis assays demonstrated that polymerase (pol) ζ was the most likely candidate polymerase that is responsible for the G to T mutations induced by this adduct.</pubmed_abstract><journal>Carcinogenesis</journal><pubmed_title>Molecular basis of aflatoxin-induced mutagenesis-role of the aflatoxin B1-formamidopyrimidine adduct.</pubmed_title><pmcid>PMC4076807</pmcid><funding_grant_id>R01 GM032431</funding_grant_id><funding_grant_id>P01 CA160032</funding_grant_id><funding_grant_id>P30 ES000267</funding_grant_id><funding_grant_id>P30 CA068485</funding_grant_id><funding_grant_id>GM 032431</funding_grant_id><funding_grant_id>T32 ES007028</funding_grant_id><funding_grant_id>R01 CA055678</funding_grant_id><funding_grant_id>T32 GM071338</funding_grant_id><funding_grant_id>P30 ES00267</funding_grant_id><pubmed_authors>Lin YC</pubmed_authors><pubmed_authors>Stone MP</pubmed_authors><pubmed_authors>Makarova AV</pubmed_authors><pubmed_authors>Lloyd RS</pubmed_authors><pubmed_authors>Li L</pubmed_authors><pubmed_authors>Burgers PM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Molecular basis of aflatoxin-induced mutagenesis-role of the aflatoxin B1-formamidopyrimidine adduct.</name><description>Aflatoxin B1 (AFB1) is a known carcinogen associated with early-onset hepatocellular carcinoma (HCC) and is thought to contribute to over half a million new HCCs per year. Although some of the fundamental risk factors are established, the molecular basis of AFB1-induced mutagenesis in primate cells has not been rigorously investigated. To gain insights into genome instability that is produced as a result of replicating DNAs containing AFB1 adducts, site-specific mutagenesis assays were used to establish the mutagenic potential of the persistent ring-opened AFB1 adduct, AFB1-formamidopyrimidine (AFB1-FAPY). This lesion was highly mutagenic, yielding replication error frequencies of 97%, with the predominant base substitution being a G to T transversion. This transversion is consistent with previous mutational data derived from aflatoxin-associated HCCs. In vitro translesion synthesis assays demonstrated that polymerase (pol) ζ was the most likely candidate polymerase that is responsible for the G to T mutations induced by this adduct.</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Jul</publication><modification>2025-04-04T10:09:02.259Z</modification><creation>2019-03-27T01:31:07Z</creation></dates><accession>S-EPMC4076807</accession><cross_references><pubmed>24398669</pubmed><doi>10.1093/carcin/bgu003</doi></cross_references></HashMap>